LaRose v. Am. Med. Response of Conn., Inc.

CourtCourt of Appeals for the Second Circuit
DecidedMay 29, 2025
Docket24-962
StatusUnpublished

This text of LaRose v. Am. Med. Response of Conn., Inc. (LaRose v. Am. Med. Response of Conn., Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
LaRose v. Am. Med. Response of Conn., Inc., (2d Cir. 2025).

Opinion

24-962 LaRose v. Am. Med. Response of Conn., Inc.

UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT

SUMMARY ORDER

RULINGS BY SUMMARY ORDER DO NOT HAVE PRECEDENTIAL EFFECT. CITATION TO A SUMMARY ORDER FILED ON OR AFTER JANUARY 1, 2007, IS PERMITTED AND IS GOVERNED BY FEDERAL RULE OF APPELLATE PROCEDURE 32.1 AND THIS COURT’S LOCAL RULE 32.1.1. WHEN CITING A SUMMARY ORDER IN A DOCUMENT FILED WITH THIS COURT, A PARTY MUST CITE EITHER THE FEDERAL APPENDIX OR AN ELECTRONIC DATABASE (WITH THE NOTATION “SUMMARY ORDER”). A PARTY CITING A SUMMARY ORDER MUST SERVE A COPY OF IT ON ANY PARTY NOT REPRESENTED BY COUNSEL.

At a stated term of the United States Court of Appeals for the Second Circuit, held at the Thurgood Marshall United States Courthouse, 40 Foley Square, in the City of New York, on the 29th day of May, two thousand twenty-five.

PRESENT: RICHARD J. SULLIVAN, JOSEPH F. BIANCO, STEVEN J. MENASHI, Circuit Judges. _____________________________________

ROBERT LAROSE,

Plaintiff-Appellant,

v. No. 24-962

AMERICAN MEDICAL RESPONSE OF CONNECTICUT, INC.,

Defendant-Appellee. _____________________________________ For Plaintiff-Appellant: Peter D. Goselin, The Law Office of Peter Goselin, Hartford, CT.

For Defendant-Appellee: John P. Shea, Jackson Lewis P.C., Hartford, CT.

Appeal from a judgment of the United States District Court for the District

of Connecticut (Vernon D. Oliver, Judge).

UPON DUE CONSIDERATION, IT IS HEREBY ORDERED,

ADJUDGED, AND DECREED that the February 26, 2024 judgment of the district

court is AFFIRMED.

Robert LaRose appeals from the district court’s grant of summary judgment

in favor of his former employer, American Medical Response of Connecticut, Inc.

(“AMR”), on his claim that AMR interfered with his rights under the Family

Medical Leave Act (the “FMLA”), 29 U.S.C. § 2601, et seq., when it refused to

reinstate him as a supervisor after his FMLA leave expired. We assume the parties’

familiarity with the underlying facts, procedural history, and issues on appeal.

We review a district court’s grant of summary judgment de novo and view

the evidence in the light most favorable to the non-moving party below. See James

v. N.Y. Racing Ass’n, 233 F.3d 149, 152 (2d Cir. 2000). Summary judgment is

appropriate “only when there is no genuine issue as to any material fact.” Id. A

2 dispute is “genuine” when the evidence on the issue “would permit a reasonable

juror to find for the party opposing the motion.” Figueroa v. Mazza, 825 F.3d 89, 98

(2d Cir. 2016).

The FMLA affords qualified employees who cannot work due to a “serious

health condition” up to twelve weeks of leave in a year. 29 U.S.C. § 2612(a)(1)(D).

To prevail on an FMLA interference claim, LaRose must establish that: (1) he was

eligible for FMLA benefits, (2) AMR was subject to the FMLA, (3) he was entitled

to FMLA leave, (4) he gave notice to AMR of his intention to take leave, and (5) he

was denied FMLA benefits to which he was entitled. See Graziadio v. Culinary Inst.

of Am., 817 F.3d 415, 424 (2d Cir. 2016). The FMLA grants an employee two distinct

rights: the right to take leave for the treatment of a serious health condition, see 29

U.S.C. § 2612(a)(1), and the right to be reinstated to his former position or an

equivalent position at the end of leave, see id. § 2614(a). An employer is responsible

for designating leave as “FMLA-qualifying, and for giving notice of the

designation to the employee.” 29 C.F.R. § 825.300(d)(1). If the information

provided by the employer in the designation notice changes (e.g., if the employee

exhausts his FMLA leave entitlement), the employer must provide written notice

to the employee. See id. § 825.300(d)(5). Failure to follow the notice requirements

3 may constitute an interference with “the exercise of an employee’s FMLA rights,”

id. § 825.300(e), but that failure is actionable only if the plaintiff can demonstrate

that it prejudiced him, see Ragsdale v. Wolverine World Wide, Inc., 535 U.S. 81, 90–91

(2002).

There is no dispute that LaRose has met the first four elements of an FMLA

interference claim. It is likewise undisputed that LaRose received his twelve

weeks of FMLA leave, which expired on February 15, 2019. The sole issue on

appeal is whether the district court erred in concluding that AMR was entitled to

summary judgment on LaRose’s claim that AMR interfered with his right to

reinstatement under the FMLA.

LaRose first argues that the district court erred by ignoring evidence that he

may have requested reinstatement to his position prior to February 15, 2019, the

date that his FMLA leave expired. But LaRose is equivocal as to whether he made

such a request “a few days before or a few days after his FMLA” leave expired.

Appellant Br. at 17. He merely contends – for the first time on appeal – that while

he does “not remember the date of the conversation,” he may have spoken to

Robert Retallick, his manager at AMR, about reinstatement prior to the expiration

of his FMLA leave. Id. at 16–17. Such vague assertions are insufficient to create a

4 genuine dispute of material fact. See F.D.I.C. v. Nat'l Union Fire Ins. Co. of

Pittsburgh, 205 F.3d 66, 75 (2d Cir. 2000) (“[V]ague denials and memory lapses . . .

do not create genuine issues of material fact.”). Moreover, LaRose admits in his

own Local Rule 56(a)(2) Statement in the district court that he spoke with Retallick

about his “continued employment at AMR” when he visited AMR after February

22, 2019. J. App’x at 387; see also id. at 3-4 (LaRose alleging in his complaint that

the conversation with Retallick occurred “[o]n or about February 27, 2019”); id. at

361, 370 (LaRose stating the same in his memorandum opposing summary

judgment); id. at 400 (LaRose stating the same in a request for admission). In any

event, since LaRose never argued to the district court that he may have requested

reinstatement prior to the exhaustion of his FMLA leave on February 15, 2019, he

has forfeited this argument on appeal. See In re Nortel Networks Corp. Sec. Litig.,

539 F.3d 129, 132 (2d Cir. 2008).

LaRose next contends that the district court erred by overlooking AMR’s

failure to provide him with a timely FMLA designation notice, as required by 29

C.F.R. § 825.300(d)(5). But AMR’s failure to provide LaRose with such notice could

not have interfered with his right to reinstatement for the simple reason that

LaRose was not physically able to return to work until May, almost three months

5 after his leave expired in February 2019.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
LaRose v. Am. Med. Response of Conn., Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/larose-v-am-med-response-of-conn-inc-ca2-2025.